Baxter reports first-quarter 2022 results

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a global medtech leader, today reported results for the first quarter of 2022. “our positive momentum in the first quarter of 2022 was fueled by the diversity and durability of our medically essential product portfolio – dynamics that have further strengthened with our recent acquisition of hillrom,” said josÉ (joe) e. almeida, chairman, president and chief executive officer. “as we continue to navigate the impact of covid-
BAX Ratings Summary
BAX Quant Ranking